Real-time SEC alerts Start Free →
Profitelligence
Intuitive Surgical, Inc.
ISRG LOW Impact

Intuitive Surgical, Inc.

Intuitive Surgical Reports Strong Preliminary 2023 Results

| 8-K |Healthcare

Summary

Intuitive Surgical, Inc. announced preliminary unaudited fourth quarter and full year 2023 financial results, showing significant growth in worldwide da Vinci procedures and revenue. For Q4 2023, worldwide da Vinci procedures grew by approximately 21% compared to Q4 2022, and revenue increased by 17% to approximately $1.93 billion. Full-year 2023 procedures grew by about 22% and revenue by 14% to approximately $7.12 billion. The company placed 415 da Vinci systems in Q4 2023, an increase of 12% from Q4 2022. Intuitive expects worldwide da Vinci procedures to increase by approximately 13% to 16% in 2024.

Profitelligence Profitelligence Alerts

Get alerts for ISRG

Be first to know when Intuitive Surgical, Inc. files with the SEC.

Set Up Alerts →

Filing Categories

General Statement Exhibits Furnished

Exhibits (2)

Advertisement

About Intuitive Surgical, Inc.

Intuitive Surgical, Inc. is a pioneering company in the field of robotic-assisted, minimally invasive surgery. It is renowned for its development of the da Vinci Surgical System, which revolutionizes surgical procedures by enhancing precision, flexibility, and control beyond the physical capabilities of the human hand. The company's cornerstone product allows surgeons to perform complex surgeries through small incisions, which can lead to quicker patient recovery, reduced hospital stays, and lower complication rates. Operating predominantly in the healthcare sector, Intuitive Surgical serves a significant role in advancing surgical technology and improving patient outcomes. The company collaborates across diverse medical specialties, including urology, gynecology, and general surgery, to expand the applications and accessibility of its robust surgical systems. As an innovator in the medical device industry, Intuitive Surgical has a profound impact not only on surgical methodologies but also on the economic aspects of medical practices by potentially lowering surgical costs. It continues to shape the future of surgery with its commitment to enhancing robotic-assisted techniques.

Exchange: NASDAQ Industry: Medical Instruments & Supplies Company Website →

Official SEC Documents

ISRG
ISRG Research
8Ks, insider trades, financials, technicals
SEC Alert Manager
Get alerts within 60 seconds of new filings

Advertisement